drugset / Trial / NCT06179732

Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communities

NCT06179732 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of this study is to determine the effectiveness of a new spatial repellent (called Mesh) at repelling multiple disease vectors and, reducing clinical malaria rates in temporary shelters and camp settings. The design of the study will be a two-armed cluster randomised trial. By conducting the research in challenging camp settings in the north of Nigeria, the MENTOR Initiative aims to determine whether Mesh can be effective in harsh camp conditions where communities are living in conflict area temporary shelters.

Timeline

Start
2023-06-05
Primary completion
2023-12-31
Completion
2023-12-31

Outcome

Met primary endpoint

paper spatial repellent emanators significantly reduced malaria infection incidence over 6 months of follow-up (incidence rate ratio 0·713, 95% CI 0·584-0·869; p=0·001; PMID 41520670 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject transfluthrin Small molecule 2500 mg Other